Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

<< Previous
Bullboard Posts
Next >>
Post by fossi_2002on Feb 23, 2024 9:35am
91 Views
Post# 35895304

Vote

VoteHope, I also had to ask after the press release was published and complain about the control numbers.
By the way, the following is important: Cut-off is 8.3.2024

Today's news release is interesting for me in one respect: one major customer has resumed ordering from Ceapro during Q1/2024 with a +20 metric ton order of avenanthramides. However, this order of magnitude tells me nothing at all, as I have no comparison with the quarters in previous years. Perhaps someone can help me in this regard.

We will be hearing a lot more from Proph about all the other points in the coming days/weeks. He will certainly be excited or enthuastic.





<< Previous
Bullboard Posts
Next >>